Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 16 of 20
Lenalidomide in HTLV-1 Adult T-Cell Leukemia
NCT01274533
Electro-acupuncture for the Prevention of Taxane Induced Myalgias and Neuropathy
NCT01163682
Clinical Trial of Exercise in Patients With Spinal Muscular Atrophy (SMA)
NCT01166022
Prenatal Effects of Congenital Heart Disease (CHD) on Neurodevelopmental Outcome
NCT00713635
Keratoconus Detection by Ultrasound
NCT01403129
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
NCT01556230
Real-time Influenza Vaccine Surveillance
NCT01233388
Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease
NCT01247090
Intracervical Lidocaine Gel for IUD Insertional Pain
NCT01214161
Pulsed Electromagnetic Fields (PEMF) and Post-Axillary Surgery Morbidity
NCT01255631
Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
NCT01221181
Reducing Sleep Disparities in Minority Children
NCT01301989
Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus
NCT01298999
TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations
NCT01146912
HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.
NCT01154296
Probiotic Use in Children Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
NCT01010867
Radius Loading in Primary Hyperparathyroidism
NCT01571843
Use of Pulsed Electromagnetic Fields (PEMF) After Breast Reconstruction Surgery
NCT01262599
Cognitive Control and Physical Exercise
NCT01183819
Comparison of Depression Interventions After Acute Coronary Syndrome
NCT01032018
The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure
NCT00944229
Hypothermic Machine Preservation-Phase 2
NCT01274520
FluAlert: Influenza Vaccine Alerts for Providers in the Electronic Health Record
NCT01146899
HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism
NCT01199614
Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)
NCT01129284
The Multimedia HIV/STI Prevention for Drug-Involved Female Offenders
NCT01784809
Family Cardiac Caregiver Investigation to Evaluate Outcomes
NCT00990548
Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation
NCT00930579
Effects of Nicotine Replacement and Repeated Cue Exposure on Cigarette Craving
NCT01329614
Adjuvant Valproate for High Grade Sarcomas
NCT01010958
Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma
NCT01129167
Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors
NCT00998036
The Use of Music for Pain and Anxiety Control During Abortion
NCT01013363
Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
NCT00976131
Effect of Number of Meals on Metabolism After Weight Loss Surgery
NCT02929212
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
NCT01129557
Use of PET Imaging to Distinguish Malignant From Benign IPMN
NCT01104116
Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT00881556
Lesser Tuberosity Osteotomy for Subscapularis Repair
NCT02762903
Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET
NCT01065818
Prehypertension Labeling
NCT01434953
Stool Testing for Pancreatic Cancer
NCT01104129
Revlimid in Transfusion Dependent Patients
NCT01178814
Vitamin D in Postmenopausal Women at High Risk for Breast Cancer
NCT00859651
A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy
NCT00998166
Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors
NCT00930527
Improving Antimicrobial Prescribing Practices in the Neonatal ICU
NCT03079245
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary
NCT01397721
PANDA (Pediatric Anesthesia & NeuroDevelopment Assessment) Study
NCT00881764
Acceptance of Human Papillomavirus Vaccination in Postpartum Women
NCT00730704
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Columbia University pipeline card: 958 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.